scanX
Home
Lincoln Pharmaceuticals

Lincoln Pharmaceuticals

695.60
+25.40
(3.79%)
Market Cap (₹ Cr.)
₹1,342
52 Week High
811.85
Book Value
₹296
52 Week Low
472.00
PE Ratio
13.69
PB Ratio
2.26
PE for Sector
56.01
PB for Sector
19.89
ROE
14.51 %
ROCE
20.35 %
Dividend Yield
0.27 %
EPS
₹48.91
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
15.43 %
Net Income Growth
27.99 %
Cash Flow Change
61.03 %
ROE
8.48 %
ROCE
4.81 %
EBITDA Margin (Avg.)
4.21 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
61
61
79
83
95
80
73
66
88
90
89
78
74
99
102
82
77
96
113
98
81
103
124
115
82
122
131
123
104
130
146
140
116
143
165
157
150
158
Expenses
55
51
70
72
86
63
60
57
82
81
73
61
64
75
82
68
68
77
88
84
68
81
94
95
64
96
98
96
85
107
112
107
96
115
125
117
124
125
EBITDA
6
10
9
11
9
17
13
9
6
8
16
17
10
24
20
14
9
19
25
14
13
22
29
21
18
26
33
26
19
23
35
33
21
28
40
41
25
33
Operating Profit %
11 %
13 %
7 %
9 %
1 %
17 %
14 %
9 %
7 %
7 %
15 %
19 %
12 %
22 %
16 %
16 %
12 %
18 %
20 %
12 %
10 %
20 %
23 %
17 %
19 %
20 %
23 %
20 %
17 %
14 %
21 %
20 %
15 %
15 %
20 %
20 %
13 %
15 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
1
2
2
2
2
2
2
2
3
3
3
3
3
Interest
2
2
1
2
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
0
Profit Before Tax
3
8
7
8
7
14
11
7
4
6
13
16
8
22
18
11
7
17
24
12
11
21
27
18
15
24
31
24
17
21
32
31
17
25
37
38
22
29
Tax
1
2
2
3
2
3
2
1
1
1
4
4
1
6
5
2
1
5
5
2
2
5
7
5
3
7
8
6
5
6
8
8
3
6
9
7
4
6
Net Profit
2
6
5
5
5
11
8
5
4
5
10
11
7
16
14
9
7
12
18
10
9
15
20
13
13
17
23
18
11
15
24
22
13
19
28
28
19
24
EPS in ₹
1.17
3.73
3.33
3.15
3.12
6.51
4.86
2.50
1.93
2.25
4.97
5.57
3.59
7.80
7.20
4.73
3.59
6.08
8.99
5.09
4.62
7.50
10.10
6.73
6.28
8.69
11.50
8.79
5.50
7.49
11.84
10.79
6.27
9.49
13.81
14.00
9.28
11.82
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
192
242
282
326
347
367
452
534
587
700
Fixed Assets
33
63
68
83
88
91
111
132
151
179
Current Assets
131
134
154
190
195
215
308
353
367
447
Capital Work in Progress
3
3
7
0
2
0
2
16
7
3
Investments
0
0
36
39
46
60
81
97
91
139
Other Assets
156
176
171
204
211
216
259
289
339
378
Total Liabilities
81
103
92
106
84
63
85
101
85
107
Current Liabilities
74
86
76
91
76
55
75
90
72
92
Non Current Liabilities
7
17
16
16
8
7
10
11
13
15
Total Equity
111
139
190
220
263
304
366
433
502
593
Reserve & Surplus
95
122
170
200
243
284
346
413
482
573
Share Capital
16
16
20
20
20
20
20
20
20
20
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
-0
-0
4
-1
4
-1
-4
-2
1
Investing Activities
-5
-40
-26
-14
-22
-29
-64
-78
-37
-57
Operating Activities
9
29
18
21
51
71
69
76
39
63
Financing Activities
-5
11
8
-4
-30
-38
-6
-3
-4
-5
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
37.26 %
37.78 %
40.28 %
42.08 %
42.05 %
44.08 %
44.08 %
46.34 %
47.00 %
48.67 %
50.53 %
49.80 %
49.53 %
49.78 %
FIIs
0.00 %
0.01 %
0.75 %
0.95 %
0.77 %
0.64 %
0.64 %
1.44 %
1.27 %
1.74 %
2.59 %
3.23 %
3.93 %
3.95 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.05 %
0.04 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
62.74 %
62.21 %
58.97 %
56.97 %
57.19 %
55.28 %
55.28 %
52.22 %
51.73 %
49.58 %
46.88 %
46.91 %
46.49 %
46.24 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,369.90 1,15,057.82 68.77 10,785.75 11.59 1,656 20.90 46.64
Ajanta Pharma
3,253.60 39,958.76 46.80 4,293.31 11.77 816 18.09 54.72
Gland Pharma
1,800.80 29,575.41 40.96 5,834.96 50.97 772 -25.94 37.78
Eris Lifesciences
1,324.25 18,099.35 47.59 2,032.96 19.85 397 -4.52 49.04
Caplin Point Laboratories
2,078.20 14,423.60 30.20 1,761.04 15.65 461 19.85 63.72
Marksans Pharma
300.15 13,511.08 40.45 2,227.83 16.55 315 26.45 61.73
Shilpa Medicare
835.70 7,954.80 193.68 1,159.77 8.64 32 1,091.53 54.53
Jeena Sikho Lifecare
1,562.10 3,826.60 114.61 207.35 40.06 34 - 64.84
Amrutanjan Health Care
795.15 2,358.67 55.39 192.42 12.50 21 -34.09 51.89
Hester Biosciences
2,444.90 2,079.38 107.44 315.18 12.07 21 11.62 47.56

Corporate Action

Technical Indicators

RSI(14)
Neutral
44.16
ATR(14)
Volatile
26.84
STOCH(9,6)
Oversold
10.11
STOCH RSI(14)
Oversold
9.64
MACD(12,26)
Bearish
-10.72
ADX(14)
Strong Trend
27.80
UO(9)
Bearish
34.27
ROC(12)
Downtrend But Slowing Down
-9.25
WillR(14)
Neutral
-76.31
Bearish
4
Neutral
2
Bullish
3
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.